Table 2.

HTm4 expression in human cancers by immunohistochemistry

Tissue type	Histology	Case	Average HTm4 intensity
		(N)	Mean ±S.E.
Testis	Seminoma	7	1.93 ±0.37
Endometrium	Adenocarcinoma	11	1.50 ±0.32
Ovary	Adenocarcinoma	10	1.40 ±0.31
Breast	Ductal Carcinoma	28	1.38 ±0.18
Prostate	Adenocarcinoma	18	1.36 ±0.28
Skin	Basal cell carcinoma	4	1.25 ±0.72
Bladder	Transitional cell carcinoma	18	1.03 ±0.20
Brain	Glioblastoma	3	1.00 ±0.00
Colon	Adenocarcinoma	18	0.81 ±0.17
Pancreas	Adenocarcinoma	12	0.75 ±0.20
Liver	Adenocarcinoma	10	0.75 ±0.40
Lung	Adenocarcinoma	18	0.78 ±0.13
Gallbladder	Squamous cell carcinoma	3	0.67 ±0.44
Cervix	Squamous cell carcinoma	11	0.64 ±0.32
Gastric	Adenocarcinoma	13	0.62 ±0.18
Head and neck	Squamous cell carcinoma	44	0.51 ±0.11
Oesophagus	Squamous cell carcinoma	12	0.38 ±0.16
Kidney	Adenocarcinoma; renal cell carcinoma; clear cell carcinoma	13	0.27 ±0.12

HTm4 staining Intensity Criteria:

0: absent; 0.5: trace; 1: weak; 1.5: weak plus; 2: moderate;

2.5: moderate plus; 3: strong; 3.5: strong plus.